Diagnosis and Treatment of Multiple Sclerosis: A Review.
McGinley MP, Goldschmidt CH, Rae-Grant AD.
JAMA. 2021 Feb 23;325(8):765-779. doi: 10.1001/jama.2020.26858.
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.
Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.
Eur J Neurol. 2018 Feb;25(2):215-237. doi: 10.1111/ene.13536. Epub 2018 Jan 19.
Health benefits of combined oral contraceptives - a narrative review.
Coelingh Bennink HJT, van Gennip FAM, Gerrits MGF, Egberts JFM, Gemzell-Danielsson K, Kopp-Kallner H.
Eur J Contracept Reprod Health Care. 2024 Apr;29(2):40-52. doi: 10.1080/13625187.2024.2317295. Epub 2024 Mar 1.
Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies.
Iyer P, Dobson R.
Neurol Ther. 2023 Feb;12(1):1-10. doi: 10.1007/s40120-022-00421-0. Epub 2022 Nov 28.
Contraception for women with multiple sclerosis: Guidance for healthcare providers.
Houtchens MK, Zapata LB, Curtis KM, Whiteman MK.
Mult Scler. 2017 May;23(6):757-764. doi: 10.1177/1352458517701314. Epub 2017 Mar 24.
The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results.
Thiel S, Ciplea AI, Gold R, Hellwig K.
Ther Adv Neurol Disord. 2021 Nov 22;14:17562864211054956. doi: 10.1177/17562864211054956. eCollection 2021.
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.
Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.
Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.
Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score.
Bsteh G, Hegen H, Riedl K, Altmann P, Di Pauli F, Ehling R, Zulehner G, Rommer P, Leutmezer F, Deisenhammer F, Berger T.
Front Neurol. 2022 Jan 17;12:766956. doi: 10.3389/fneur.2021.766956. eCollection 2021.
Osteopathia Striata with Cranial Sclerosis.
Gear R, Savarirayan R.
2021 Apr 15 [updated 2023 Mar 30]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project.
Lopez-Leon S, Geissbühler Y, Sabidó M, Turkson M, Wahlich C, Morris JK.
J Neurol. 2020 Sep;267(9):2721-2731. doi: 10.1007/s00415-020-09913-1. Epub 2020 May 22.
